Why Trump’s ‘Great Healthcare Plan’ strikes Wall Street as so underwhelming

The Trump administration on Thursday rolled out what it’s calling the “Great Healthcare Plan,” with elements…

Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead

Published: Jan. 15, 2026 at 11:51 a.m. ET Millions of Americans have tried GLP-1s, but some people…

A new generation of weight-loss drugs is getting closer to patients. Here’s how they differ from Wegovy and Zepbound.

Published: Dec. 18, 2025 at 9:28 a.m. ET Eli Lilly and Novo Nordisk — the dominant players…

Eli Lilly’s stock has crushed Nvidia’s in recent weeks. What history has to say about that.

Published: Dec. 17, 2025 at 2:28 p.m. ET The recent rotation into healthcare stocks and out of…

Eight stock picks to play one of the healthiest corners of the market

Published: Dec. 11, 2025 at 10:37 a.m. ET The healthcare sector of the U.S. stock market as…

Eli Lilly’s newest weight-loss drug relieved pain in patients with knee osteoarthritis

Published: Dec. 11, 2025 at 7:55 a.m. ET One of Eli Lilly’s most promising new obesity drugs…

Structure Therapeutics details positive trial data for a weight-loss pill, and the stock rockets

Published: Dec. 8, 2025 at 9:12 a.m. ET Structure Therapeutics’ stock soared toward an 18-month high in…

Is GLP-1 the new AI? Drugmaker Eli Lilly briefly joins the $1 trillion market-cap club.

Published: Nov. 21, 2025 at 10:40 a.m. ET Eli Lilly is the first pharmaceutical stock to hit…

Why cutting drug prices is pushing Eli Lilly’s stock toward an all-time high

Published: Nov. 11, 2025 at 3:20 p.m. ET Eli Lilly & Co.’s stock is once again in…

Trump rolls out pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk. Analysts say the pact raises more questions than it answers.

Jessica Hall is a retirement reporter for MarketWatch. She was an Age Boom Academy Fellow with…